I now have comprehensive information for a full clinical response.
Patient: Mrs. Nazia, 30 years | Primary Infertility 8 years | Irregular Menses
Investigation Summary
| Test | Result | Normal (Follicular) | Interpretation |
|---|
| FSH | 5.616 mIU/l | 3.0–12.0 | ✅ Normal |
| LH | 3.892 mIU/ml | 2.12–10.89 | ✅ Normal range, but LH:FSH ratio low (0.69:1 - no LH surge) |
| Prolactin | 13.75 ng/ml | <25 ng/ml | ✅ Normal (borderline - watch) |
| TSH | 1.342 uIU/ml | 0.27–4.20 | ✅ Normal |
| USS Pelvis | Left ovary polycystic (4.5×4.0 cm), multiple peripheral follicles + central echogenic stroma | - | PCOS pattern |
DIAGNOSIS
Polycystic Ovary Syndrome (PCOS) - Rotterdam Criteria
PCOS is diagnosed when 2 of 3 criteria are met (Rotterdam 2003, confirmed NIH 2012):
| Rotterdam Criterion | This Patient |
|---|
| 1. Oligomenorrhea / Anovulation | ✅ YES - irregular menses, 8 years infertility |
| 2. Polycystic ovaries on USS | ✅ YES - left ovary with peripheral follicles + echogenic stroma |
| 3. Hyperandrogenism (clinical/biochemical) | Not reported - needs assessment (acne, hirsutism, testosterone) |
2 out of 3 criteria confirmed = PCOS diagnosis established.
Note: Classical PCOS shows elevated LH:FSH ratio (>2:1 or >3:1), but this is not required for diagnosis - Berek & Novak's Gynecology states: "Documentation of elevated serum LH:FSH ratios and hyperinsulinemia are not required for either diagnosis or treatment of PCOS."
MANAGEMENT PLAN
Step 1 - Complete the Work-up (Before Treatment)
- Fasting insulin + fasting glucose (HOMA-IR for insulin resistance)
- Serum testosterone + DHEAS (to rule out adrenal tumor or congenital adrenal hyperplasia)
- 17-OH Progesterone (rule out non-classical CAH)
- Semen analysis of husband (essential after 8 years of infertility)
- HSG (hysterosalpingography) - to confirm tubal patency before starting ovulation induction
- BMI assessment - obesity worsens PCOS outcomes
Step 2 - Lifestyle Modification (First-Line)
- Weight loss if overweight: even a 5% reduction in body weight improves ovulation and pregnancy rates
- Regular exercise + caloric restriction (reduce 500 kcal/day)
- This should be initiated before pharmacologic treatment
Step 3 - Ovulation Induction (Primary Goal - Conception)
First-line: Letrozole (preferred over Clomiphene per current evidence)
"Letrozole can be recommended as first-line treatment because of higher ovulation, pregnancy and live birth rate." - Berek & Novak's Gynecology
| Drug | Dose | Timing | Notes |
|---|
| Letrozole (Femara) | 2.5–5 mg/day × 5 days | Day 3–7 of cycle | Drug of choice - higher live birth rate (27.5% vs 19.1% vs Clomiphene) |
| Clomiphene Citrate | 50 mg/day × 5 days | Day 3–7 | Alternative if Letrozole unavailable |
- A 2024 meta-analysis (PMID 38030814) and a 2025 meta-analysis (PMID 40660210) both confirm Letrozole is superior to Clomiphene in PCOS for ovulation and live birth rates.
- Dose can be increased by 2.5 mg each cycle if no follicular response on USS monitoring
- Maximum 6 ovulatory cycles or 12 total cycles
Add Metformin (adjunct)
- Metformin 500 mg BD or 850 mg BD (titrate slowly to avoid GI side effects)
- Addresses underlying insulin resistance
- Metformin + Letrozole/Clomiphene combination improves ovulation rates vs. drug alone
Step 4 - Cycle Monitoring
- Follicle tracking USS at Day 10–12 to assess follicle size (target: dominant follicle ≥18 mm)
- hCG trigger injection (10,000 IU IM) when follicle ≥18 mm to induce ovulation
- Timed intercourse 36–40 hours after hCG trigger
- Midluteal progesterone (Day 21) to confirm ovulation
Step 5 - If Ovulation Induction Fails (6 cycles)
- Gonadotropin therapy (injectable FSH +/- LH) - with intensive USS monitoring (risk of OHSS)
- Laparoscopic Ovarian Drilling (LOD) - bilateral ovarian drilling; restores spontaneous ovulation in ~50% of clomiphene-resistant PCOS
- IVF - if above measures fail or husband's semen analysis is abnormal
Step 6 - Metabolic Screening (Long-term)
- Fasting glucose / HbA1c annually (PCOS carries increased T2DM risk)
- Fasting lipid panel
- Endometrial monitoring (chronic anovulation = increased endometrial hyperplasia risk)
Prolactin Note
Prolactin 13.75 ng/ml is within normal limits. However, borderline elevated prolactin can suppress GnRH. If this patient fails initial treatment cycles, a repeat fasting prolactin (to exclude stress-related elevation) and pituitary MRI should be considered to rule out microadenoma.
Summary Prescription Plan
1. Letrozole 2.5 mg - Day 3 to Day 7 of cycle
2. Metformin 500 mg BD (increase to 1000 mg BD after 4 weeks)
3. Folic acid 5 mg OD (pre-conception)
4. Follicle tracking USS Day 10-12
5. hCG 10,000 IU when follicle ≥18 mm
6. Timed intercourse post-trigger
7. Husband: Semen analysis
8. HSG to confirm tubal patency
⚠️ This clinical analysis is for educational purposes. Final treatment decisions must be made by a qualified gynecologist/reproductive endocrinologist based on full clinical examination.